Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma. | Cancers (Basel) | 2024 | 38473425 | PubTator, text mining | PubMed |
| Common proteins analysis of different mammals' mature milk by 4D-Label-Free. | Food Chem X | 2024 | 38465331 | PubTator, text mining | PubMed |
| LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma. | Aging (Albany NY) | 2024 | 38393692 | PubTator, text mining | PubMed |
| Identification and validation of a novel 9-gene signature of non-specific classification to predict prognosis in glioma patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38372105 | PubTator, text mining | PubMed |
| Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia. | Transplant Proc | 2024 | 38360465 | PubTator, text mining | PubMed |
| Integrated plasma proteomics and N-glycoproteomics reveals alterations in the N-glycosylation in Chinese hepatocellular carcinoma patients. | Proteomics Clin Appl | 2024 | 38345243 | PubTator, text mining | PubMed |
| Galectin-3-binding protein and future venous thromboembolism. | Res Pract Thromb Haemost | 2024 | 38327613 | PubTator, text mining | PubMed |
| Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. | Cancer Sci | 2024 | 38321872 | PubTator, text mining | PubMed |
| Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma. | PLoS One | 2024 | 38306361 | PubTator, text mining | PubMed |
| Proteomic analysis of the extracellular matrix of human atherosclerotic plaques shows marked changes between plaque types. | Matrix Biol Plus | 2024 | 38292008 | PubTator, text mining | PubMed |
| Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy. | Sci Rep | 2024 | 38291117 | PubTator, text mining | PubMed |
| Impaired bisecting GlcNAc reprogrammed M1 polarization of macrophage. | Cell Commun Signal | 2024 | 38279161 | PubTator, text mining | PubMed |
| Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma. | Cancers (Basel) | 2024 | 38275876 | PubTator, text mining | PubMed |
| The functional role of CST1 and CCL26 in asthma development. | Immun Inflamm Dis | 2024 | 38270326 | PubTator, text mining | PubMed |
| Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. | J Proteome Res | 2024 | 38266179 | PubTator, text mining | PubMed |
| Neurodegenerative Disease: From Molecular Basis to Therapy. | Int J Mol Sci | 2024 | 38256040 | PubTator, text mining | PubMed |
| Oral Chagas Disease in Colombia-Confirmed and Suspected Routes of Transmission. | Trop Med Infect Dis | 2024 | 38251211 | PubTator, text mining | PubMed |
| Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients. | Dig Dis | 2024 | 38219719 | PubTator, text mining | PubMed |
| Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents. | Oncology | 2024 | 38211572 | PubTator, text mining | PubMed |
| Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis. | Jpn Dent Sci Rev | 2024 | 38204964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=10